Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 107,941 | 290,895 | 114,846 | 154,842 | 139,833 |
| Marketable Securities | 267,437 | 111,978 | 301,977 | 281,737 | 296,518 |
| Receivables | 84,156 | 70,250 | 63,080 | 56,136 | 68,889 |
| Inventories | 9,199 | 6,095 | 6,636 | 5,844 | 6,327 |
| TOTAL | $492,628 | $502,850 | $507,937 | $521,552 | $532,519 |
| Non-Current Assets | |||||
| PPE Net | 5,193 | 5,595 | 6,021 | 6,510 | 7,016 |
| Intangibles | 68,219 | 69,583 | 0 | 0 | 0 |
| Other Non-Current Assets | 76,729 | 77,277 | 73,854 | 74,429 | 73,231 |
| TOTAL | $150,141 | $152,455 | $79,875 | $80,939 | $80,247 |
| Total Assets | $642,769 | $655,305 | $587,812 | $602,491 | $612,766 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,811 | 17,422 | 12,746 | 10,008 | 11,854 |
| Accrued Expenses | 169,131 | 206,879 | 112,884 | 106,562 | 105,827 |
| TOTAL | $187,942 | $224,301 | $125,630 | $116,570 | $117,681 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 59,034 | 56,746 | 61,769 | 60,235 | 60,237 |
| TOTAL | $59,034 | $56,746 | $61,769 | $60,235 | $60,237 |
| Total Liabilities | $246,976 | $281,047 | $187,399 | $176,805 | $177,918 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 163,729 | 162,625 | 162,230 | 161,931 | 161,843 |
| Common Shares | 16 | 16 | 16 | 16 | 16 |
| Retained earnings | -2,411,458 | -2,412,572 | -2,369,551 | -2,327,826 | -2,300,643 |
| Other shareholders' equity | -535 | -220 | -975 | -1,365 | -843 |
| TOTAL | $395,793 | $374,258 | $400,413 | $425,686 | $434,848 |
| Total Liabilities And Equity | $642,769 | $655,305 | $587,812 | $602,491 | $612,766 |